PBE Holdings Information

PBE is an equity ETF with a total of 33 individual holdings. The top holdings are United Therapeutics stock at 6.06%, Illumina at 5.44%, Alnylam Pharmaceuticals at 5.23%, Regeneron Pharmaceuticals at 5.14%, and Biogen at 5.13%.

Total Holdings

Top 10 Percentage

48.70%

Asset Class

Equity

ETF Category

Health

Assets

242.83M

PE Ratio

18.14

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	UTHR	United Therapeutics Corporation	6.06%	27,212
2	ILMN	Illumina, Inc.	5.44%	104,832
3	ALNY	Alnylam Pharmaceuticals, Inc.	5.23%	38,706
4	REGN	Regeneron Pharmaceuticals, Inc.	5.14%	16,684
5	BIIB	Biogen Inc.	5.13%	66,025
6	GILD	Gilead Sciences, Inc.	4.96%	87,264
7	AMGN	Amgen Inc.	4.90%	33,651
8	INCY	Incyte Corporation	4.83%	127,499
9	BCRX	BioCryst Pharmaceuticals, Inc.	3.57%	923,458
10	PTGX	Protagonist Therapeutics, Inc.	3.45%	80,415
11	TGTX	TG Therapeutics, Inc.	3.01%	230,335
12	RPRX	Royalty Pharma plc	2.99%	154,791
13	NBIX	Neurocrine Biosciences, Inc.	2.89%	53,660
14	CPRX	Catalyst Pharmaceuticals, Inc.	2.84%	290,513
15	PTCT	PTC Therapeutics, Inc.	2.79%	101,877
16	ARWR	Arrowhead Pharmaceuticals, Inc.	2.76%	110,374
17	EXEL	Exelixis, Inc.	2.74%	155,682
18	CDNA	CareDx, Inc.	2.71%	365,065
19	VCYT	Veracyte, Inc.	2.65%	196,903
20	TECH	Bio-Techne Corporation	2.64%	122,004
21	HALO	Halozyme Therapeutics, Inc.	2.60%	99,880
22	ACAD	ACADIA Pharmaceuticals Inc.	2.59%	285,787
23	BMRN	BioMarin Pharmaceutical Inc.	2.56%	112,225
24	IONS	Ionis Pharmaceuticals, Inc.	2.46%	82,240
25	RGEN	Repligen Corporation	2.45%	52,183

Showing 25 of 33 holdings

Subscribe to see the full list

Activate Now

As of Mar 25, 2026